Clinical course of COVID-19 disease in immunosuppressed renal transplant patients

Hamad Dheir Sava S Sipahi Selcuk Yaylacı Esma Seda Çetin Ahmed Bilal Genc Necattin Fırat Mehmet Köroğlu Gürkan Muratdağı Yakup Tomak Kezban Özmen Süner Ömer Faruk Ateş Yasemin Gündüz

Published in: Turkish journal of medical sciences (2021)

Renal transplant patients are considered a high risk group for COVID-19. It can be said that discontinuation or reducing dosages of immunosuppressives may be effective and safe in kidney transplant patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
coronavirus disease
prognostic factors
patient reported outcomes